Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Post-Traumatic Stress Disorder | Treatment Algorithms: Claims Data Analysis | US | 2023
Multiple guidelines recommend treating post-traumatic stress disorder (PTSD) first with psychotherapy, but such approaches do not suffice for many patients, necessitating the use of pharmacological…
Major Depressive Disorder | Treatment Algorithms: Claims Data Analysis | US | 2023
Major depressive disorder (MDD) is a highly drug-treated condition that uses an array of drug classes, including, but not limited to, selective serotonin reuptake inhibitors (SSRIs), selective…
Irritable Bowel Syndrome | Treatment Algorithms: Claims Data Analysis | IBS-constipation (including IBS without diarrhea) | US | 2023
Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder characterized by alterations in motility, stool consistency and frequency, and urgency. It is classified into three subtypes:…
Crohn’s Disease | Treatment Algorithms: Claims Data Analysis | Adult | US | 2023
Crohn’s disease (CD) is a chronic inflammatory disorder of the gastrointestinal tract characterized by diarrhea, abdominal pain, and weight loss. The primary goal of CD treatment is to induce and…
Generalized Anxiety Disorder – Current Treatment – Treatment Algorithms: Claims Data Analysis – Generalized Anxiety Disorder (US)
The use of pharmacotherapies for the treatment of generalized anxiety disorder (GAD) has grown sharply, fueled by an increasing prevalence of the disorder and constrained access to nonpharmacologic…
